Total Payments
$7,353
2024 Payments
$556.47
Companies
39
Transactions
408
Medicare Patients
3,586
Medicare Billing
$703,034
Payment Breakdown by Category
Food & Beverage$7,263 (98.8%)
Education$89.99 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,263 | 407 | 98.8% |
| Education | $89.99 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,577 | 89 | $0 (2024) |
| Amgen Inc. | $1,099 | 65 | $0 (2024) |
| PFIZER INC. | $781.54 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $527.39 | 21 | $0 (2024) |
| UCB, Inc. | $500.40 | 26 | $0 (2023) |
| Lilly USA, LLC | $432.72 | 25 | $0 (2024) |
| Celgene Corporation | $365.73 | 23 | $0 (2019) |
| Genentech USA, Inc. | $352.87 | 21 | $0 (2021) |
| GENZYME CORPORATION | $344.90 | 16 | $0 (2024) |
| Novo Nordisk Inc | $316.75 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $556.47 | 28 | ABBVIE INC. ($181.04) |
| 2023 | $1,153 | 58 | Amgen Inc. ($269.34) |
| 2022 | $1,628 | 86 | ABBVIE INC. ($416.02) |
| 2021 | $1,205 | 73 | AbbVie Inc. ($498.00) |
| 2020 | $564.95 | 29 | AbbVie Inc. ($182.59) |
| 2019 | $925.36 | 56 | PFIZER INC. ($187.86) |
| 2018 | $733.38 | 45 | Celgene Corporation ($194.70) |
| 2017 | $586.59 | 33 | Allergan Inc. ($97.71) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | GENZYME CORPORATION | KEVZARA (Biological), KEVZARA, KEVZARA | Food and Beverage | In-kind items and services | $35.37 | General |
| Category: Rheumatology | ||||||
| 05/24/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2024 | GENZYME CORPORATION | KEVZARA (Biological), KEVZARA | Food and Beverage | In-kind items and services | $35.91 | General |
| Category: Rheumatology | ||||||
| 04/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: IMMUNOLOGY | ||||||
| 04/08/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Inflammation | ||||||
| 04/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Immunology | ||||||
| 03/29/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Inflammation | ||||||
| 03/19/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: IMMUNOLOGY | ||||||
| 02/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Inflammation | ||||||
| 01/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 897 | 2,118 | $258,114 | $174,400 |
| 2022 | 12 | 711 | 1,862 | $234,519 | $155,190 |
| 2021 | 14 | 883 | 2,142 | $257,044 | $173,642 |
| 2020 | 15 | 1,095 | 2,490 | $303,904 | $199,803 |
Total Patients
3,586
Total Services
8,612
Medicare Billing
$703,034
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 284 | 1,277 | $183,533 | $119,769 | 65.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 68 | 213 | $21,919 | $16,826 | 76.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 103 | 103 | $13,246 | $12,390 | 93.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 50 | $9,909 | $6,549 | 66.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 36 | 48 | $5,005 | $3,924 | 78.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $5,213 | $2,752 | 52.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 19 | 21 | $3,671 | $2,646 | 72.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 16 | 17 | $3,973 | $2,257 | 56.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 36 | 46 | $3,239 | $1,993 | 61.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 21 | 22 | $3,647 | $1,868 | 51.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 108 | 108 | $2,160 | $1,820 | 84.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 84 | 108 | $2,188 | $1,410 | 64.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 36 | 50 | $315.56 | $109.37 | 34.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 14 | 22 | $95.04 | $86.68 | 91.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 292 | 1,225 | $173,878 | $112,047 | 64.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 74 | 226 | $23,242 | $17,207 | 74.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 57 | $11,296 | $8,594 | 76.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $6,044 | $5,788 | 95.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $5,845 | $3,805 | 65.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 32 | 40 | $4,171 | $3,097 | 74.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $5,922 | $1,822 | 30.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 71 | 111 | $2,070 | $1,378 | 66.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 49 | 49 | $980.00 | $831.96 | 84.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 16 | $922.72 | $502.94 | 54.5% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 18 | 23 | $99.36 | $91.42 | 92.0% |
About Dr. Alan Struth, M.D
Dr. Alan Struth, M.D is a Internal Medicine healthcare provider based in Warner Robins, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619990033.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Struth, M.D has received a total of $7,353 in payments from pharmaceutical and medical device companies, with $556.47 received in 2024. These payments were reported across 408 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,263).
As a Medicare-enrolled provider, Struth has provided services to 3,586 Medicare beneficiaries, totaling 8,612 services with total Medicare billing of $703,034. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Warner Robins, GA
- Active Since 07/26/2006
- Last Updated 08/27/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619990033
Products in Payments
- RINVOQ (Biological) $947.37
- Enbrel (Biological) $893.24
- XELJANZ (Drug) $727.71
- Cimzia (Drug) $500.40
- REMICADE (Biological) $284.92
- TALTZ (Drug) $229.99
- TREMFYA (Drug) $218.45
- Rituxan (Biological) $206.91
- KEVZARA (Biological) $197.72
- RINVOQ (Drug) $158.09
- VRAYLAR (Drug) $154.02
- KEVZARA (Drug) $147.18
- Actemra (Biological) $130.09
- Ozempic (Drug) $123.04
- BENLYSTA (Biological) $121.58
- Otezla (Drug) $108.59
- HUMIRA (Biological) $106.77
- Victoza (Drug) $102.49
- SKYRIZI (Biological) $93.00
- NURTEC ODT (Drug) $79.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Warner Robins
Anilkumar Pillai, M.d, M.D
Internal Medicine — Payments: $68,168
Internal Medicine $68,168
Dr. Mohammad Al Shroof, M.d, M.D
Internal Medicine — Payments: $25,857
Internal Medicine $25,857
Dr. Ravindraprasad Shekarappa, M.d, M.D
Internal Medicine — Payments: $14,868
Internal Medicine $14,868
Michael Brady, Md, MD
Internal Medicine — Payments: $14,181
Internal Medicine $14,181
Javed Fazal, M.d, M.D
Internal Medicine — Payments: $12,412
Internal Medicine $12,412
Gayatri Kamat, M.d, M.D
Internal Medicine — Payments: $11,649
Internal Medicine $11,649